Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome

Journal of Clinical Investigation

Volumn 109, Issue 6, 2002, Pages 797-804

  Blank, Miri ^a   Krause, Ilan ^a   Fridkin, Mati ^b   Keller, Nathan ^c   Kopolovic, Juri ^c   Goldberg, Iris ^c   Tobar, Ana ^a   Shoenfeld, Yehuda ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BACTERIAL PROTEIN; BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY; TETANUS TOXOID; THROMBOPLASTIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS WASTAGE; HAEMOPHILUS INFLUENZAE; IMMUNIZATION; IMMUNOBLOTTING; MOLECULAR MIMICRY; MOUSE; NEISSERIA GONORRHOEAE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PASSIVE IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0036196287     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0212337     Document Type: Article

References (44)

1. The anticardiolipin syndrome
2. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H)
3. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor
4. β2GP-I in the antiphospholipid (Hughes') syndrome - From a cofactor to an autoantigen - From induction to prevention of antiphospholipid syndrome
5. Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H)
6. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice
7. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome
8. The antiphospholipid syndrome in infectious diseases
9. Antiphospholipid antibody syndrome associated with hepatitis C infection
10. Mycoplasma penettans bacteremia and primary antiphospholipid syndrome
11. Systemic lupus erythematosus-associated catastrophic antiphospholipid syndrome occurring after typhoid fever: A possible role of Salmonella lipopolysaccharide in the occurrence of diffuse vasculopathy-coagulopathy
12. The relationship of antiphospholipid antibodies to infections-do they bind to infecting agents or may they even be induced by them
13. Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients
14. Molecular mimicry and immune-mediated diseases
15. Molecular mimicry between nonself, modified self and self in autoimmunity
16. Molecular mimicry and autoimmunity
17. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity
18. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats
19. Coxsackievirus-induced chronic myocarditis in murine models
20. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice
21. Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection
22. Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: Experimental autoimmune encephalomyelitis induction in TCR transgenic mice
23. A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis
24. Mechanisms for the induction of autoimmunity by infectious agents
25. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides
26. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)
27. A common anti-cardiolipin antibody idiotype, in autoimmune disease: Identification using a mouse monoclonal antibody directed against a naturally-occurring anti-phospholipid antibody
28. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
29. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
30. Anticardiolipin antibodies in infections are hererogenous in their dependency on beta 2-glycoprotein 1: Analysis of anticardiolipin antibodies in leprosy
31. Beta2-glycoprotein I-dependent anticardiolipin antibodies as risk factor for reactions in borderline leprosy patients
32. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus
33. Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia
34. Staphylococcus aureus expresses a cell surface protein that binds both IgG and beta2-glycoprotein 1
35. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides
36. Crystal structure of human beta2-glycoprotein I: Implications for phospholipid binding and the antiphospholipid syndrome
37. Impaired thrombin generation in beta 2-glycoprotein I null mice
38. The large bacillus plasmid pTB19 contains two integrated rolling-circle plasmids carrying mobilization functions
39. Genetic and biochemical analysis of Shigella dysenteriae 1 O antigen polysaccharide biosynthesis in Escherichia coli K-12: Structure and functions of the rfb gene cluster
40. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd
41. A novel determinant (comA) essential for natural transformation competence in Neisseria gonorrhoeae and the effect of a comA defect on pilin variation
42. Limited proteolysis of tetanus toxin. Relation to activity and identification of cleavage sites
43. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
44. PHR1, a pH-regulated gene of Candida albicans, is required for morphogenesis